(Q37099369)

18 August 2017

1 reference

title

Exercise and urologic cancers (English)

1 reference

18 August 2017

Jacqueline S Drouin

1

1 reference

18 August 2017

Jerome Beeler

series ordinal

2

1 reference

18 August 2017

publication date

1 March 2008

1 reference

18 August 2017

1 reference

18 August 2017

volume

26

1 reference

18 August 2017

issue

2

1 reference

18 August 2017

page(s)

205-212

1 reference

Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

A meta-analysis of exercise interventions among people treated for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical exercise results in the improved subjective well-being of a few or is effective rehabilitation for all cancer patients?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and cancer risk: dose-response and cancer, all sites and site-specific

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and risk of cancer in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Review and critique of the quality of exercise recommendations for cancer patients and survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

How much physical activity should we do? The case for moderate amounts and intensities of physical activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Bone health in men receiving androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Osteoporosis in men treated with androgen suppression therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Osteoporosis due to androgen deprivation therapy in men with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Late effects of adjuvant radiotherapy for breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Images in cardiovascular medicine. Radiation therapy-induced cardiac injury.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Bronchoalveolar lavage in bronchiolitis obliterans organizing pneumonia primed by radiation therapy to the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

The effect on pulmonary function of tangential field technique in radiotherapy for carcinoma of the breast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Drug-induced congestive heart failure in breast cancer survivors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

The spectrum of vascular lesions in the mammary skin, including angiosarcoma, after breast conservation treatment for breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Is radiation treatment volume a predictor for acute or late effect on pulmonary function? A prospective study of patients treated with breast-conserving surgery and postoperative irradiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Complementary therapies for reducing the risk of osteoporosis in patients receiving luteinizing hormone-releasing hormone treatment/orchiectomy for prostate cancer: a review and assessment of the need for more research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Random control clinical trial on the effects of aerobic exercise training on erythrocyte levels during radiation treatment for breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Cancer rehabilitation: particularly with aspects on physical impairments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity interventions following cancer diagnosis: methodologic challenges to delivery and assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise and side effects among 749 patients during and after treatment for cancer: a University of Rochester Cancer Center Community Clinical Oncology Program Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Aerobic exercise in the rehabilitation of cancer patients after high dose chemotherapy and autologous peripheral stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Effect of aerobic exercise and relaxation training on fatigue and physical performance of cancer patients after surgery. A randomised controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Correlation between physical performance and fatigue in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical performance, depression, immune status and fatigue in patients with hematological malignancies after treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Effects of endurance training on the physical performance of patients with hematological malignancies during chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise and physical health: cancer and immune function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and cancer prevention: etiologic evidence and biological mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Resistance Exercise in Men Receiving Androgen Deprivation Therapy for Prostate Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Resistance Training and Reduction of Treatment Side Effects in Prostate Cancer Patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Changes in body composition during hormonal therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Role of testosterone, estradiol, and insulin in diet- and exercise-induced reductions in serum-stimulated prostate cancer cell growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise, cachexia, and cancer therapy: a molecular rationale

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Prostate cancer: another aspect of the insulin-resistance syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

A low-fat diet and/or strenuous exercise alters the IGF axis in vivo and reduces prostate tumor cell growth in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Progressive osteoporosis during androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Skeletal fracture associated with androgen suppression induced osteoporosis: the clinical incidence and risk factors for patients with prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Cancer-treatment-induced bone loss, part 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Cancer-treatment-induced bone loss, part 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Lifestyle recommendations to prevent prostate cancer, part II: time to redirect our attention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Lifestyle recommendations to prevent prostate cancer, part I: time to redirect our attention?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Osteoporosis during androgen deprivation therapy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical Activity and Cancer Prevention???Data from Epidemiologic Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Reduction of the individual cancer risk by physical exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Cancers of the prostate, penis, and testicles: epidemiology, prevention, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

A review of physical activity and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

The association between cardiorespiratory fitness and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Is exercise beneficial in the prevention of prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise and prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Does physical activity play a role in the prevention of prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Recreational Physical Activity and Prostate Cancer Risk (United States)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and the risk of prostate and testicular cancer: a cohort study of 53,000 Norwegian men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Recreational physical activity and risk of prostate cancer: A prospective population-based study in Norway (the HUNT study)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Prostate cancer, benign prostatic hyperplasia and physical activity in Shanghai, China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical Activity and the Risk of Prostate Cancer in The Netherlands Cohort Study, Results after 9.3 Years of Follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and prostate cancer in the Alpha-Tocopherol, Beta-Carotene (ATBC) Cancer Prevention Study (Finland).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. Cohort.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Case-control study of lifetime total physical activity and prostate cancer risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

A prospective study of physical activity and risk of prostate cancer in US physicians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Intensive lifestyle changes may affect the progression of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Training enhances vascular relaxation after chemotherapy-induced vasoconstriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Low-intensity exercise training during doxorubicin treatment protects against cardiotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise training attenuates acute doxorubicin-induced cardiac dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Aerobic exercise as therapy for cancer fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Advising patients who seek complementary and alternative medical therapies for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Exercise in the prevention and treatment of cancer. An update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

Radiotherapy-related fatigue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.10.009

10.1016/J.UROLONC.2007.10.009

7 January 2021

Identifiers

DOI

1 reference

18 August 2017

1 reference